Participated · Equity · Jun 2026

Nanordica Medical’s core product, Premotiv, is a patent-protected wound dressing designed to prevent infection while promoting healing without relying on systemic antibiotics. In a randomised controlled trial of 30 patients with diabetic foot ulcers, Premotiv demonstrated a 43% reduction in wound area after one week versus 13% with standard silver dressings, with results published in the Journal of Wound Care. The company is conducting a larger multicentre, double-blind, randomised clinical trial with more than 120 patients enrolled to generate stronger evidence for reimbursement and guideline adoption. Nanordica launched a veterinary product, Ravimus Vet, in 2023 which is distributed in six countries, and has been awarded a European patent. The company has received a €2.4 million EIC Accelerator grant to support clinical and development activities and intends to pursue CE marking for the human product prior to European launch.

Participated · Seed · May 2026

OTee develops a software-defined control platform that replaces traditional PLC hardware by running safety-critical control systems on open, off-the-shelf hardware. Its engineering platform is designed for designing, deploying, and managing virtual control systems using open architecture and standards, aiming to remove vendor lock-in and lower costs. The company positions itself against established PLC vendors by emphasizing openness and open integration. OTee targets energy, utilities, and manufacturing customers and plans to expand internationally using proceeds from its seed round. At the time of the raise it had 21 employees from 13 countries. The company raised €5.3 million in seed funding led by North Ventures to accelerate product development and market expansion.

Participated · Seed · Apr 2026

Spiral Hydrogen is developing a rotating, bubble-free electrolyser that routes gases through a porous electrode into a dedicated channel to avoid bubble-related efficiency losses. The company says this approach enables efficiency levels above 90%, which could lower capital and operating costs for green hydrogen production. Founders Juri Volodin and Fedor Stomakhin combine expertise in electrochemistry, energy systems, and software engineering. The startup aims to validate the technology with a pilot at the Port of Rotterdam in partnership with SwitcH2, targeting completion within two years. Success at pilot scale is intended to inform the design of a first commercial unit. Spiral Hydrogen raised €2.7M in pre-seed funding plus €0.7M in grants to support the pilot transition.

Participated · Series A · Mar 2026

Freestyle makes premium diapers and wipes that pair a patent-pending seven-layer absorbency system with non-toxic, Total Chlorine Free, EWG-Verified materials to protect babies’ sensitive skin while delivering strong leak protection. Founded by parents, the company began as a digitally native brand and has since expanded into Walmart, Target, Whole Foods, Amazon, and other national outlets, quickly building an omnichannel presence. Management highlights robust repeat purchasing and word-of-mouth growth as it captures millennial and Gen Z parents seeking cleaner, higher-performance alternatives to legacy diaper brands. With a recently secured $10 million Series A, Freestyle now plans to deepen product innovation, broaden its portfolio, and invest in supply-chain scale and brand marketing. The capital will also support community-driven initiatives aimed at strengthening customer loyalty. While revenue figures were not disclosed, the company points to rapid retail sell-through and a growing digital customer base as validation of early traction. Overall, Freestyle positions itself to lead the next generation of skin-conscious, performance-driven baby care.

Led · Seed · Dec 2025

UForce was incorporated in the United Kingdom in January 2025 by former Ukrainian Prime Minister Oleksiy Honcharuk and People.ai founder Oleg Rogynskyy to aggregate and scale Ukraine’s most battle-tested autonomous systems. The company positions itself as a defense-technology operating platform that contracts directly with governments to deliver complete combat systems under its “Neoprime” model, combining its own products with those of subcontractors. Its portfolio includes the Magura and Mykola-3 unmanned surface vessels, Nemesis strike drones, the R18/R34/R36 bomber drones, Fury ground robots, laser counter-UAS systems, and the Ground Control and SICH command-and-control software suites. Unlike traditional defense contractors that rely on prototypes, UForce offers equipment already proven in active conflict. The firm aims to export these solutions to Ukraine’s allies facing stability threats. UForce has already reached unicorn status, with a valuation exceeding $1 billion following its latest financing. The fresh capital is intended to expand production and accelerate deployment of its autonomous platforms.